Regulatory Reform Breaks Down: Has FDA Blown An “Historic Opportunity”?
This article was originally published in The Rose Sheet
Executive Summary
Returning to the discussion table with industry on a legislative plan for updated cosmetics oversight would ensure that a year’s work does not go wasted while presenting FDA the opportunity to increase its resources significantly and elevate the agency’s global stature, according to industry consultant John Bailey, former director of FDA’s cosmetics office and chief scientist at the Personal Care Products Council.